Natixis Accolade, Inc. Transaction History
Natixis
- $16 Billion
- Q4 2024
A detailed history of Natixis transactions in Accolade, Inc. stock. As of the latest transaction made, Natixis holds 286,600 shares of ACCD stock, worth $1.99 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
286,600Holding current value
$1.99 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ACCD
# of Institutions
172Shares Held
62.4MCall Options Held
27.3KPut Options Held
1.36M-
Black Rock Inc. New York, NY6.16MShares$42.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.66MShares$32.3 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.18MShares$29 Million0.0% of portfolio
-
Ah Equity Partners Iv (Parallel), L.L.C. Menlo Park, CA3.78MShares$26.2 Million88.81% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.48MShares$24.1 Million0.29% of portfolio
About Accolade, Inc.
- Ticker ACCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 71,938,896
- Market Cap $499M
- Description
- Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...